-
Je něco špatně v tomto záznamu ?
Reduction of oxidative stress does not attenuate the development of angiotensin II-dependent hypertension in Ren-2 transgenic rats
L. Kopkan, Z. Husková, Z. Vaňourková, M. Thumová, P. Škaroupková, J. Malý, H.J. Kramer, P. Dvořák, L. Červenka
Jazyk angličtina Země Spojené státy americké
Typ dokumentu práce podpořená grantem
- MeSH
- acetofenony farmakologie MeSH
- analýza rozptylu MeSH
- angiotensin II analýza fyziologie krev moč MeSH
- antioxidancia farmakologie MeSH
- časové faktory MeSH
- cyklické N-oxidy farmakologie MeSH
- dinoprost analogy a deriváty moč MeSH
- hypertenze komplikace patofyziologie prevence a kontrola MeSH
- kardiomegalie komplikace prevence a kontrola MeSH
- krevní tlak MeSH
- krysa rodu rattus MeSH
- ledviny chemie MeSH
- malondialdehyd analýza MeSH
- modely nemocí na zvířatech MeSH
- myokard chemie MeSH
- náhodné rozdělení MeSH
- nemoci ledvin komplikace prevence a kontrola MeSH
- oxidační stres fyziologie MeSH
- potkani Sprague-Dawley MeSH
- potkani transgenní MeSH
- proteinurie MeSH
- renin genetika MeSH
- scavengery volných radikálů farmakologie MeSH
- spinové značení MeSH
- zvířata MeSH
- Check Tag
- krysa rodu rattus MeSH
- mužské pohlaví MeSH
- zvířata MeSH
- Publikační typ
- práce podpořená grantem MeSH
Results of our previous studies have suggested that enhanced generation of superoxide (O2(-)) may contribute to the pathophysiology of hypertension in Ren-2 transgenic rats (TGR). The present study was performed to evaluate in TGR the effects of chronic treatment with the O2(-) scavenger tempol and the antioxidant apocynin on the development of hypertension. Systolic blood pressure (SBP) was monitored from 30 to 99 days of age in TGR and in normotensive Hannover Sprague-Dawley (HanSD) rats. At the end of the experiment, urinary protein and 8-isoprostane excretion were determined and angiotensin II (ANG II) and malondialdehyde (MDA) levels were measured in kidney and cardiac tissues. Cardiac hypertrophy was assessed as the ratio of left heart ventricle weight to tibia length (LVW/TL). Although tempol and apocynin treatment in TGR significantly decreased 8-isoprostane excretion and MAD tissue concentrations as compared with untreated TGR, it did not alter the course of SBP, LVW/TL ratio, proteinuria or ANG II levels that were enhanced as compared with HanSD rats. Our data suggest that the development of hypertension in TGR is clearly ANG II-dependent but the contribution of oxidative stress to the development of hypertension in this model appears to be negligible.
- 000
- 03950naa 2200709 a 4500
- 001
- bmc11022998
- 003
- CZ-PrNML
- 005
- 20121114111735.0
- 008
- 110801s2009 xxu e Eng||
- 009
- AR
- 040 __
- $a ABA008 $b cze $c ABA008 $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xxu
- 100 1_
- $a Kopkan, Libor $7 xx0107287
- 245 10
- $a Reduction of oxidative stress does not attenuate the development of angiotensin II-dependent hypertension in Ren-2 transgenic rats / $c L. Kopkan, Z. Husková, Z. Vaňourková, M. Thumová, P. Škaroupková, J. Malý, H.J. Kramer, P. Dvořák, L. Červenka
- 314 __
- $a Department for Experimental Medicine, Institute for Clinical and Experimental Medicine, 1958/9 Videnska, CZ-140 21 Prague 4, Czech Republic.
- 520 9_
- $a Results of our previous studies have suggested that enhanced generation of superoxide (O2(-)) may contribute to the pathophysiology of hypertension in Ren-2 transgenic rats (TGR). The present study was performed to evaluate in TGR the effects of chronic treatment with the O2(-) scavenger tempol and the antioxidant apocynin on the development of hypertension. Systolic blood pressure (SBP) was monitored from 30 to 99 days of age in TGR and in normotensive Hannover Sprague-Dawley (HanSD) rats. At the end of the experiment, urinary protein and 8-isoprostane excretion were determined and angiotensin II (ANG II) and malondialdehyde (MDA) levels were measured in kidney and cardiac tissues. Cardiac hypertrophy was assessed as the ratio of left heart ventricle weight to tibia length (LVW/TL). Although tempol and apocynin treatment in TGR significantly decreased 8-isoprostane excretion and MAD tissue concentrations as compared with untreated TGR, it did not alter the course of SBP, LVW/TL ratio, proteinuria or ANG II levels that were enhanced as compared with HanSD rats. Our data suggest that the development of hypertension in TGR is clearly ANG II-dependent but the contribution of oxidative stress to the development of hypertension in this model appears to be negligible.
- 590 __
- $a bohemika - dle Pubmed
- 650 _2
- $a acetofenony $x farmakologie $7 D000098
- 650 _2
- $a analýza rozptylu $7 D000704
- 650 _2
- $a angiotensin II $x analýza $x fyziologie $x krev $x moč $7 D000804
- 650 _2
- $a zvířata $7 D000818
- 650 _2
- $a antioxidancia $x farmakologie $7 D000975
- 650 _2
- $a krevní tlak $7 D001794
- 650 _2
- $a kardiomegalie $x komplikace $x prevence a kontrola $7 D006332
- 650 _2
- $a cyklické N-oxidy $x farmakologie $7 D003497
- 650 _2
- $a dinoprost $x analogy a deriváty $x moč $7 D015237
- 650 _2
- $a modely nemocí na zvířatech $7 D004195
- 650 _2
- $a scavengery volných radikálů $x farmakologie $7 D016166
- 650 _2
- $a hypertenze $x komplikace $x patofyziologie $x prevence a kontrola $7 D006973
- 650 _2
- $a ledviny $x chemie $7 D007668
- 650 _2
- $a nemoci ledvin $x komplikace $x prevence a kontrola $7 D007674
- 650 _2
- $a mužské pohlaví $7 D008297
- 650 _2
- $a malondialdehyd $x analýza $7 D008315
- 650 _2
- $a myokard $x chemie $7 D009206
- 650 _2
- $a oxidační stres $x fyziologie $7 D018384
- 650 _2
- $a proteinurie $7 D011507
- 650 _2
- $a náhodné rozdělení $7 D011897
- 650 _2
- $a krysa rodu Rattus $7 D051381
- 650 _2
- $a potkani Sprague-Dawley $7 D017207
- 650 _2
- $a potkani transgenní $7 D055647
- 650 _2
- $a renin $x genetika $7 D012083
- 650 _2
- $a spinové značení $7 D013113
- 650 _2
- $a časové faktory $7 D013997
- 655 _2
- $a práce podpořená grantem $7 D013485
- 700 1_
- $a Husková, Zuzana, $d 1978- $7 xx0074206
- 700 1_
- $a Vaňourková, Zdeňka, $d 1973- $7 xx0074217
- 700 1#
- $a Thumová, Monika. $7 _AN037603
- 700 1_
- $a Škaroupková, Petra $7 xx0117683
- 700 1_
- $a Malý, Jan, $d 1943-2021 $7 nlk19990073523
- 700 1_
- $a Kramer, Herbert J. $7 xx0085908
- 700 1#
- $a Dvořák, Pavel. $7 xx0114163
- 700 1_
- $a Červenka, Luděk, $d 1967- $7 xx0037105
- 773 0_
- $t Vascular Pharmacology $w MED00008593 $g Roč. 51, č. 2-3 (2009), s. 175-181 $x 1537-1891
- 910 __
- $a ABA008 $b x $y 2
- 990 __
- $a 20110802094606 $b ABA008
- 991 __
- $a 20121114111750 $b ABA008
- 999 __
- $a ok $b bmc $g 881854 $s 732927
- BAS __
- $a 3
- BMC __
- $a 2009 $b 51 $c 2-3 $d 175-181 $m Vascular pharmacology $n Vascul Pharmacol $i 1537-1891 $x MED00008593
- LZP __
- $a 2011-4B09/jvme